Active Ingredient(s): Prucalopride Succinate
FDA Approved: * December 14, 2018
Pharm Company: * SHIRE DEV LLC
Category: Laxative

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Motegrity Overview

Prucalopride, brand names Resolor and Motegrity among others, is a drug acting as a selective, high affinity 5-HT4 receptor agonist[1] which targets the impaired motility associated with chronic constipation, thus normalizing bowel movements.[2][3][4][5][6][7] Prucalopride was approved for medical use in the European Union in 2009,[8] in Canada in 2011,[9&...

Read more Motegrity Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Motegrity Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Prucalopride Succinate
  • Tablet: 1mg, 2mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Motegrity: (2 results)

Sorted by National Drug Code
  • 54092-546 Motegrity 1 mg Oral Tablet, Film Coated by Shire Us Manufacturing Inc.
  • 54092-547 Motegrity 2 mg Oral Tablet, Film Coated by Shire Us Manufacturing Inc.

Other drugs which contain Prucalopride Succinate or a similar ingredient: (2 results)